This multicenter , randomized , open-labeled , clinical trial evaluated the efficacy and safety of cisplatin/5-fluorouracil ( 5-FU ) hepatic arterial infusion chemotherapy ( CF-HAIC ) versus adriamycin adding to CF-HAIC ( ACF-HAIC ) in advanced HCC patients .